Overview of late-onset psychoses
- PMID: 36866576
- DOI: 10.1017/S1041610223000157
Overview of late-onset psychoses
Abstract
Background: Several etiologies can underlie the development of late-onset psychosis, defined by first psychotic episode after age 40 years. Late-onset psychosis is distressing to patients and caregivers, often difficult to diagnose and treat effectively, and associated with increased morbidity and mortality.
Methods: The literature was reviewed with searches in Pubmed, MEDLINE, and the Cochrane library. Search terms included "psychosis," "delusions," hallucinations," "late onset," "secondary psychoses," "schizophrenia," bipolar disorder," "psychotic depression," "delirium," "dementia," "Alzheimer's," "Lewy body," "Parkinson's, "vascular dementia," and "frontotemporal dementia." This overview covers the epidemiology, clinical features, neurobiology, and therapeutics of late-onset psychoses.
Results: Late-onset schizophrenia, delusional disorder, and psychotic depression have unique clinical characteristics. The presentation of late-onset psychosis requires investigation for underlying etiologies of "secondary" psychosis, which include neurodegenerative, metabolic, infectious, inflammatory, nutritional, endocrine, and medication toxicity. In delirium, psychosis is common but controlled evidence is lacking to support psychotropic medication use. Delusions and hallucinations are common in Alzheimer's disease, and hallucinations are common in Parkinson's disease and Lewy body dementia. Psychosis in dementia is associated with increased agitation and a poor prognosis. Although commonly used, no medications are currently approved for treating psychosis in dementia patients in the USA and nonpharmacological interventions need consideration.
Conclusion: The plethora of possible causes of late-onset psychosis requires accurate diagnosis, estimation of prognosis, and cautious clinical management because older adults have greater susceptibility to the adverse effects of psychotropic medications, particularly antipsychotics. Research is warranted on developing and testing efficacious and safe treatments for late-onset psychotic disorders.
Keywords: delirium; delusional disorder; dementia; older adult; schizophrenia; secondary psychosis.
Similar articles
-
Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.Brain. 2021 Apr 12;144(3):999-1012. doi: 10.1093/brain/awaa413. Brain. 2021. PMID: 33501939 Free PMC article.
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
Psychosis in late life: emerging issues.J Psychosoc Nurs Ment Health Serv. 2008 Nov;46(11):45-52. doi: 10.3928/02793695-20081101-09. J Psychosoc Nurs Ment Health Serv. 2008. PMID: 19051578
-
Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.J Alzheimers Dis. 2024;99(1):101-103. doi: 10.3233/JAD-240328. J Alzheimers Dis. 2024. PMID: 38669552
-
Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004. CNS Drugs. 2006. PMID: 16734499 Review.
Cited by
-
Screening indicators to evaluate the clinical significance of drug-drug interactions in polypharmacy among older adults with psychiatric disorders: a delphi study.BMC Psychiatry. 2024 Jun 4;24(1):417. doi: 10.1186/s12888-024-05872-3. BMC Psychiatry. 2024. PMID: 38834965 Free PMC article.
-
Management of neuropsychiatric symptoms in dementia.Curr Opin Neurol. 2023 Oct 1;36(5):498-503. doi: 10.1097/WCO.0000000000001199. Epub 2023 Aug 7. Curr Opin Neurol. 2023. PMID: 37639488 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical